Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation

European Journal of Human Genetics

Volumn 11, Issue 9, 2003, Pages 693-699

  Kronenberg, Florian ^a,b   Lhotta, Karl ^c   König, Paul ^c   Margreiter, Raimund ^c   Dieplinger, Hans ^a   Utermann, Gerd ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

apo(a) isoforms; Gene environment interaction; Gene gene interaction; Interaction; Kidney disease; Kidney transplantation; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN; LIPOPROTEIN A;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MOLECULAR SIZE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; APOLIPOPROTEINS; APOPROTEIN(A); DENSITOMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEMATOCRIT; HUMANS; IMMUNOBLOTTING; KIDNEY TRANSPLANTATION; LIPOPROTEIN(A); MALE; PROTEIN ISOFORMS;

EID: 0141478660     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201016     Document Type: Article

References (27)

1. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C: Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-465.
2. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH: Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991; 87: 2153-2161.
3. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
4. Kraft HG, Köchl S, Menzel HJ, Sandholzer C, Utermann G: The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992; 90: 220-230.
5. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H: Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 1996; 33: 495-543.
6. Kronenberg E, Utermann G, Dieplinger H: Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1-25.
7. Dieplinger H, Lackner C, Kronenberg F et al: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91: 397-401.
8. Kronenberg F, König P, Neyer U et al: Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 110-120.
9. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Warmer C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658.
10. Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC: Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Am J Kidney Dis 1999; 33: 1100-1106.
11. Hirata K, Kikuchi S, Saku K et al: Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int 1993; 44: 1062-1070.
12. Auguet T, Sentí M, Rubies-Prat J et al: Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein(a) genetic polymorphism. Nephrol Dial Transplant 1993; 8: 1099-1103.
13. Gazzaruso C, Bonetti G, Garzaniti A et al: Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis. Nutr Metab Cardiovasc Dis 1996; 6: 203-210.
14. Kronenberg E, König P, Lhotta K et al: Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 1994; 14: 1399-1404.
15. Kronenberg F, Lobentanz E-M, König P, Utermann G, Dieplinger H: Effect of sample storage on the measurement of lipoprotein(a), apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318-1328.
16. Kronenberg F, Trenkwalder E, Kronenberg MF, König P, Utermann G, Dieplinger H: Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). Kidney Int 1998; 54: 1385-1389.
17. Kamboh MI, Ferrell RE, Kottke BA: Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 1991; 49: 1063-1074.
18. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G: The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996; 125: 53-61.
19. Dieplinger H, Gruber G, Krasznai K et al: Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase. J Lipid Res 1995; 36: 813-822.
20. Kronenberg F, Kuen E, Ritz E et al: Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105-115.
21. Koch M, Kutkuhn B, Trenkwalder E et al: Apolipoprotein B, fibrinogen, HDL cholesterol and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997; 8: 1889-1898.
22. Kronenberg F, Trenkwalder E, Lingenhel A et al: Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J Lipid Res 1997; 38: 1755-1763.
23. Oida K, Takai H, Maeda H et al: Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 2244-2248.
24. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH: Apolipoprotein(a) kringle 4-containing fragments in urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest 1996; 97: 858-864.
25. Kostner KM, Maurer G, Huber K et al: Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler Thromb Vase Biol 1996; 16: 905-911.
26. Mooser V, Marcovina SM, White AL, Hobbs HH: Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J Clin Invest 1996; 98: 2414-2424.
27. Kerschdorfer L, König P, Neyer U et al: Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up. Atherosclerosis 1999; 144: 381-391.